These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5418476)

  • 1. Preparation of radioactive Tay-Sachs ganglioside labeled in the sialic acid moiety.
    Kolodny EH; Brady RO; Quirk JM; Kanfer JN
    J Lipid Res; 1970 Mar; 11(2):144-9. PubMed ID: 5418476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preparation of Tay-Sachs ganglioside specifically labeled in either the N-acetylneuraminosyl or N-acetylgalactosaminyl portion of the molecule.
    Tallman JF; Kolodny EH; Brady RO
    Methods Enzymol; 1975; 35():541-8. PubMed ID: 1121293
    [No Abstract]   [Full Text] [Related]  

  • 3. Demonstration of an alteration of ganglioside metabolism in Tay-Sachs disease.
    Kolodny EH; Brady RO; Volk BW
    Biochem Biophys Res Commun; 1969 Oct; 37(3):526-31. PubMed ID: 5388728
    [No Abstract]   [Full Text] [Related]  

  • 4. The metabolism of Tay-Sachs ganglioside: catabolic studies with lysosomal enzymes from normal and Tay-Sachs brain tissue.
    Tallman JF; Johnson WG; Brady RO
    J Clin Invest; 1972 Sep; 51(9):2339-45. PubMed ID: 4639018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The catabolism of Tay-Sachs ganglioside in rat brain lysosomes.
    Tallman JF; Brady RO
    J Biol Chem; 1972 Dec; 247(23):7570-5. PubMed ID: 4636324
    [No Abstract]   [Full Text] [Related]  

  • 6. The biosynthesis of gangliosides. The incorporation of galactose, N-acetylgalactosamine and N-acetylneuraminic acid into endogenous acceptors of subcellular particles from rat brain in vitro.
    Arce A; Maccioni HJ; Caputto R
    Biochem J; 1971 Feb; 121(3):483-93. PubMed ID: 5119784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On a component of the mixture of brain gangliosides, which is transferred to the Tay-Sachs ganglioside under the influence of neuraminidase].
    Klenk E; Naoi M
    Hoppe Seylers Z Physiol Chem; 1968 Mar; 349(3):288-92. PubMed ID: 4302220
    [No Abstract]   [Full Text] [Related]  

  • 8. Abnormal gangliosides in Tay-Sachs disease, Niemann-Pick's disease, and gargoylism.
    Booth DA; Goodwin H; Cumings JN
    J Lipid Res; 1966 May; 7(3):337-40. PubMed ID: 4959256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further in vivo studies on the biosynthetic relationship between the major brain gangliosides in rat.
    Holm M; Månsson JE; Svennerholm L
    FEBS Lett; 1974 Jan; 38(3):271-3. PubMed ID: 4852114
    [No Abstract]   [Full Text] [Related]  

  • 10. The biosynthesis of gangliosides. Labelling of rat brain gangliosides in vivo.
    Maccioni HJ; Arce A; Caputto R
    Biochem J; 1971 Dec; 125(4):1131-7. PubMed ID: 5144231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Concerning brain gangliosides in Tay-Sachs disease].
    Wagner A
    Klin Wochenschr; 1966 Apr; 44(7):398-402. PubMed ID: 5983851
    [No Abstract]   [Full Text] [Related]  

  • 12. Differences in the incorporation of N-(acetyl-3 H)mannosamine into the sialic acid of the major retinal gangliosides, studied in vivo.
    Holm M; Månsson JE
    FEBS Lett; 1974 Sep; 46(1):200-2. PubMed ID: 4420170
    [No Abstract]   [Full Text] [Related]  

  • 13. Tay-sachs disease. Demonstration of the stored ganglioside in cultured cells from brain biopsy.
    Batzdorf U; Sarlieve LL; Gold VA; Menkes JH
    Arch Neurol; 1969 Jun; 20(6):650-2. PubMed ID: 4890200
    [No Abstract]   [Full Text] [Related]  

  • 14. Circular dichroism of gangliosides from normal and Tay-Sachs tissues.
    Stone AL; Kolodny EH
    Chem Phys Lipids; 1971 Jul; 6(3):274-9. PubMed ID: 5571466
    [No Abstract]   [Full Text] [Related]  

  • 15. Sialic acids. Enzymatic synthesis of Tay-Sachs ganglioside.
    Steigerwald JC; Basu S; Kaufman B; Roseman S
    J Biol Chem; 1975 Sep; 250(17):6727-34. PubMed ID: 1171867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tay-sachs disease.
    Brady RO
    N Engl J Med; 1969 Nov; 281(22):1243-4. PubMed ID: 5347842
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biochemical study of cerebral and hepatic lipids in a case of Tay-Sachs disease].
    Grégoire PE; Jonniaux G; Loeb H; Voet W; Capelle R
    Rev Fr Etud Clin Biol; 1969; 14(6):568-74. PubMed ID: 5824260
    [No Abstract]   [Full Text] [Related]  

  • 18. Action of neuraminidase from Clostridium perfringens of Tay-Sachs ganglioside.
    Wenger DA; Wardell S
    Physiol Chem Phys; 1972; 4(3):224-30. PubMed ID: 4376840
    [No Abstract]   [Full Text] [Related]  

  • 19. A method of determining the sequence of incorporation of monosaccharides in the synthesis of the branched oligosaccharide chain of a structural compound. The biosynthesis of Tay-Sachs ganglioside.
    Maccioni HJ; Arce A; Caputto R
    FEBS Lett; 1972 Jun; 23(2):136-8. PubMed ID: 4634432
    [No Abstract]   [Full Text] [Related]  

  • 20. Gas--liquid chromatographic assay of lipid-bound sialic acids: measurement of gangliosides in brain of several species.
    Yu RK; Ledeen RW
    J Lipid Res; 1970 Nov; 11(6):506-16. PubMed ID: 5534017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.